Share on LinkedInShare on LinkedIn

ARTICLE · 06 AUGUST 2025

Section 3(i) Not Designed To Exclude Method Of Supplementing An Animal Feed

Another pharmaceutical patent refusal came under the Indian judicial scanner, when in Kemin Industries, Inc. vs The Controller of Patents [ CMA(PT). No.46 of 2024], the Controller refused to grant the patent [Application no.201617013577] for an invention titled "Use Of Ferulic Acid Esterase To Improve Performance In Monogastric Animals".

IndiaIntellectual Property

Another pharmaceutical patent refusal came under the Indian judicial scanner, when in Kemin Industries, Inc. vs The Controller of Patents [ CMA(PT). No.46 of 2024], the Controller refused to grant the patent [Application no.201617013577] for an invention titled "Use Of Ferulic Acid Esterase To Improve Performance In Monogastric Animals". On appeal, the Madras High Court overturned the Controller's decision of rejecting the patent application on finding that the refusal order issued under Sections 3(d), 3(i), and 2(1)(j) of the Patents Act, 1970, was unsustainable.

The principal method claims, which was refused by the Controller, read as:

"A method of reducing by 20% to 80% of the main chain degrading enzymes necessary to extract a given amount of the apparent metabolizable energy from a diet comprising feed formulated for a monogastric animal, comprising the step of adding 20 units per kg to 200 units per kg of a ferulic acid esterase produced from bacteria to

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from